Cargando…

Effect of β-blocker therapy in diabetic patients with stable coronary heart disease: a meta-analysis

BACKGROUND: β-blocker (BB) therapy is a cornerstone for the treatment of coronary heart disease (CHD). The evidence of the benefit from long-term BB therapy in diabetic patients with stable CHD is scarce. This meta-analysis summarizes the evidence relating to the BB therapy in diabetic patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malik, Aaqib H, Shetty, Suchith, Kar, Kausik, El Accaoui, Ramzi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500566/ https://www.ncbi.nlm.nih.gov/pubmed/31080472 http://dx.doi.org/10.11909/j.issn.1671-5411.2019.03.008

Ejemplares similares

A Systematic Review and Single-center Experience of Azygos Vein Defibrillator Lead Insertion
por: Yang, Ying Chi, et al.
Publicado: (2022)

Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease
por: Steg, Ph. Gabriel, et al.
Publicado: (2012)

Effects of β-blockers on all-cause mortality in patients with diabetes and coronary heart disease: A systematic review and meta-analysis
por: Chen, Shiqi, et al.
Publicado: (2023)

β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study
por: Sorbets, Emmanuel, et al.
Publicado: (2019)

β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016)

Effects of β‐blockers on all‐cause mortality in patients with type 2 diabetes and coronary heart disease
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Effect of Metoprolol Succinate in Patients with Stable Angina and Elevated Heart Rate Receiving Low-Dose β-Blocker Therapy
por: Jiang, Jie, et al.
Publicado: (2017)

Long-Term Beta-Blocker Therapy in Patients With Stable Coronary Artery Disease After Percutaneous Coronary Intervention
por: Lee, Seung-Jun, et al.
Publicado: (2022)

Association of β-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart Failure
por: Chen, Yan, et al.
Publicado: (2020)

Comparison of ivabradine plus β-blockers versus β-blocker therapy only
por: Aalbers, J
Publicado: (2010)

A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure
por: Zhang, Xiaojian, et al.
Publicado: (2016)

β1 Adrenergic Receptor Polymorphisms and Heart Failure: A Meta-Analysis on Susceptibility, Response to β-Blocker Therapy and Prognosis
por: Liu, Wen-Nan, et al.
Publicado: (2012)

The Clinical Impact of β-Blocker Therapy on Patients With Chronic Coronary Artery Disease After Percutaneous Coronary Intervention
por: Park, Jiesuck, et al.
Publicado: (2022)

Acute Left Atrial Appendage Thrombus Formation During Transcatheter Mitral Valve Edge-to-Edge Repair
por: Sharma, Vikram, et al.
Publicado: (2022)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
por: Chatterjee, Saurav, et al.
Publicado: (2013)

Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
Publicado: (2013)

Ivabradine in Combination with Beta-Blockers in Patients with Chronic Stable Angina After Percutaneous Coronary Intervention
por: Werdan, Karl, et al.
Publicado: (2015)

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015)

The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction
por: Masarone, Daniele, et al.
Publicado: (2021)

Association of β-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion
por: Hwang, Jin Kyung, et al.
Publicado: (2016)

Relationship Between β‐Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Li, Chenze, et al.
Publicado: (2016)

New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)

Mitral Valve Echodensities in a Young-Adult Female with Relapsing Polychondritis, Transiently Positive Lupus Anticoagulant, and Systemic Embolism
por: Sauer, Michael C., et al.
Publicado: (2023)

The Real Role of β-Blockers in Daily Cardiovascular Therapy
por: Dézsi, Csaba András, et al.
Publicado: (2017)

Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease
por: Lipworth, Brian, et al.
Publicado: (2016)

Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers
por: Tobin, S. W., et al.
Publicado: (2017)

Discharge β-Blocker Use and Race after Coronary Artery Bypass Grafting
por: O’Neal, Wesley T., et al.
Publicado: (2014)

Digital Maturity Consulting and Strategizing to Optimize Services: Overview
por: Phiri, Peter, et al.
Publicado: (2023)

Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials
por: Pitcher, Alex, et al.
Publicado: (2022)

Preventing β-Cell Loss and Diabetes With Calcium Channel Blockers
por: Xu, Guanlan, et al.
Publicado: (2012)

Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
por: Tsujimoto, Tetsuro, et al.
Publicado: (2017)

Autonomic dysfunction and beta blocker therapy in Chagas heart disease
por: Bestetti, Reinaldo B, et al.
Publicado: (2013)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

Complementary and alternative therapies for stable angina pectoris of coronary heart disease: A protocol for systematic review and network meta-analysis
por: Wang, Guanyu, et al.
Publicado: (2022)

β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation—a meta-analysis
por: Xu, Tianyu, et al.
Publicado: (2019)

β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure
por: Ni, Li, et al.
Publicado: (2011)

Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity?
por: McGinlay, Melanie, et al.
Publicado: (2022)

β(1)-Blockers Enhance Inotropy of Endogenous Catecholamines in Chronic Heart Failure
por: Feuerstein, Thomas J., et al.
Publicado: (2021)

β1-blocker in sepsis
por: Hasegawa, Daisuke, et al.
Publicado: (2021)

Coronary revascularization in patients with stable coronary disease and diabetes mellitus
por: Bhat, Salman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8j0g6eifs6flnhidi82od86lbg